JAB-30355

N/A

Report date: 2024/07/05 20:00:49
NME

Base Information

Drug NameJAB-30355
Drug Alias NameP53 Y220C activator(Jacobio Pharmaceuticals)JAB-30355JAB30355JAB-30300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp53 Y220C activators
Targetsp53 Y220C
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJacobio Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A